11 February 2020
In collaboration with the European Commission CEBR delivers opinions on the role and status of European life sciences ecosystems and issues recommendations designed to facilitate their incorporation into a more robust European research and innovation framework.
CEBR is a bio-community network that furthers the global competitiveness of the European biotech industry through a range of activities such as networking, business collaborations, recommendations and sharing of good practices between these regional bio-communities.
Atlanpole Biotherapies has served on the CEBR governing board since 2013. Roza Puzio, European projects manager at Atlanpole Biotherapies, has spent over a year working on this presentation with her EU counterparts.